4//SEC Filing
PHARMACEUTICAL PRODUCT DEVELOPMENT INC 4
Accession 0001181153-07-000003
CIK 0001003124operating
Filed
May 29, 8:00 PM ET
Accepted
May 30, 11:36 AM ET
Size
28.6 KB
Accession
0001181153-07-000003
Insider Transaction Report
Form 4
COVINGTON PAUL S
Executive Vice President
Transactions
- Sale
Common Stock
2007-05-29$35.13/sh−1,050$36,887→ 8,781 total - Exercise/Conversion
Common Stock
2007-05-29$15.30/sh+13,334$204,010→ 22,115 total - Sale
Common Stock
2007-05-29$35.20/sh−10,000$352,000→ 23,781 total - Sale
Common Stock
2007-05-29$35.21/sh−2,800$98,588→ 20,981 total - Sale
Common Stock
2007-05-29$35.14/sh−700$24,598→ 9,831 total - Sale
Common Stock
2007-05-29$35.26/sh−2,600$91,676→ 8,781 total - Sale
Common Stock
2007-05-29$35.28/sh−1,200$42,336→ 11,381 total - Exercise/Conversion
Stock Options (to buy)
2007-05-29−25,000→ 50,000 totalExercise: $21.19From: 2006-11-16Exp: 2014-11-15→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2007-05-29$21.19/sh+25,000$529,750→ 47,115 total - Exercise/Conversion
Stock Options (to buy)
2007-05-29−13,334→ 0 totalExercise: $15.30From: 2006-12-03Exp: 2013-12-02→ Common Stock (13,334 underlying) - Sale
Common Stock
2007-05-29$35.11/sh−13,334$468,157→ 33,781 total
Holdings
- 30,000
Stock Options (to buy)
Exercise: $33.61From: 2008-02-21Exp: 2017-02-20→ Common Stock (30,000 underlying) - 40,000
Stock Options (to buy)
Exercise: $34.62From: 2007-02-22Exp: 2016-02-21→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]This option will vest in increments of 25,000 on 11/16/06, 11/16/07 and 11/16/08.
- [F2]This option will vest as follows: 13,333 on 2/22/07; 13,333 on 2/22/08 and 13,334 on 2/22/09.
- [F3]This option will vest in increments of 10,000 on 2/21/08, 2/21/09 and 2/21/10.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeoperating
IncorporatedNC
Related Parties
1- filerCIK 0001003124
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 11:36 AM ET
- Size
- 28.6 KB